Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
Way back in September, the document often referred to as the biennial Ryan White report was released by HRSA's HIV/AIDS Bureau (HAB).News Article updated on 11/01/2023
-
Meet the ACE TA Center: Microlearning Module
This short hello from the ACE Team is designed to welcome and orient you to the ACE TA Center.Resource updated 10/30/2023
-
Southern Interventions: Select Best Practices
Interventions applied in Southern locations, with evidence that they improve HIV care outcomes.Blog updated 08/31/2023
-
Virginia Rapid Start Collaborative
Virginia Rapid Start launched with HIV care providers across the state with goals to initiate ART for clients within 14 days of HIV diagnosis and to improve access to, and retention in, high-quality HIV care and support services. Through Virginia Rapid Start, providers initiated ART medications within an average of four days of HIV diagnosis, as compared with the statewide average of 28 days. Virginia Rapid Start clients had higher rates of viral suppression compared to both the RWHAP Part B overall and Virginia overall. The success of Virginia Rapid Start led VDH to expand the program to the entire Virginia RWHAP Part B.Resource from the RWHAP Best Practices Compilation updated on 01/18/2024
-
Konprann Doub Elijibilite: Yon Gid pou Moun ki Gen Asirans Medicare ak Medicaid
Doub elijibilite Medicare-Medicaid la kapab yon sijè konplèks ki gen anpil niyans. Zouti sa a se pou ede moun ki enfekte ak VIH konprann fondman elijibilite ak pwoteksyon asirans lan, avantaj inik ki genyen lè moun doubman elijib pou toulede pwogram yo, ansanm ak kijan Pwogram Ryan White VIH/SIDA (RWHAP) a kapab sipòte kliyan ki doubman elijib yo.
Zouti sa a abòde:
Resource updated 01/10/2024
-
Comprender la Doble Elegibilidad: Una guía para personas con VIH sobre la cobertura de Medicare y Medicaid
La doble elegibilidad para Medicare-Medicaid puede ser un asunto complejo con muchas particularidades. Este recurso fue preparado con la intención de ayudar a las personas con VIH a entender los aspectos básicos relativos a la elegibilidad y la cobertura, los beneficios particulares de ser doblemente elegible para ambos programas, y cómo el Programa Ryan White contra el VIH/SIDA (RWHAP, por sus siglas en inglés) puede apoyar a los usuarios con doble elegibilidad.
Este recurso cubre los siguientes aspectos:
Resource updated 01/10/2024
-
Tool for People with HIV: Medicare-Medicaid Dual Eligibility
You asked, we listened: New resource for people with HIV on Medicare-Medicaid dual eligibility now available.News Article updated on 01/22/2024 -
Replicating Innovative HIV Care Strategies in the RWHAP
Webinar series featuring HIV care innovations developed under HRSA SPNS projects.Resource updated 04/02/2024
-
Best Practices Highlight: New York City Medical Home Model
A New York City HIV medical home model has documented significant improvements in care re-engagement and viral suppression.Blog updated 08/23/2023
-
Understanding Dual Eligibility: A Guide for People with HIV About Medicare and Medicaid Coverage
Medicare-Medicaid dual eligibility can be a complex topic with many nuances.
This tool is intended to help people with HIV understand the basics of eligibility and coverage, the unique benefits of being dually eligible for both programs, as well as how the Ryan White HIV/AIDS Program (RWHAP) can support dually eligible clients.
This tool covers:
Resource updated 01/12/2024
-
Integration of Buprenorphine into HIV Primary Care Settings: Curriculum
The purpose of this curriculum is to provide physicians with the information they need to educate their clinic staff and other stakeholders about integrating medication-assisted treatment (MAT) with buprenorphine into HIV primary care.
It provides a detailed overview of buprenorphine within clinical settings, from the legal requirements for implementation to step-by-step procedures for prescribing and administering buprenorphine.
Resource updated 03/12/2024
-
Integration of Buprenorphine into HIV Primary Care Settings: Training Manual
Overview of training manual on integrating buprenorphine treatment into HIV primary care.
Curriculum updated on 08/01/2012 -
Integration of Buprenorphine into HIV Primary Care Settings: Curriculum
Curriculum updated on 08/01/2012 -
Buprenorphine FAQ and Peer Discussion
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.
Curriculum updated on 09/05/2012 -
Ten Years of Health Coverage Help: ACE TA Center
A decade of impact: The ACE TA Center's milestones and what’s new.News Article updated on 04/11/2024 -
EHE HIV Implementation Science Awards Track HRSA Initiatives
New grant awards for the latest round of funding of research on HIV interventions under the Ending the HIV Epidemic Initiative have been announced.News Article updated on 04/12/2024 -
Webinars on Demand: Medicare and Medicare-Medicaid Dual Eligibility for RWHAP Clients
ACE TA Center webinars covering Medicare and Medicare-Medicaid dual eligibility for RWHAP clients.News Article updated on 04/15/2024 -
Medicaid Unwinding Updates
-
Clinical Info HIV.gov
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
-
Updated Special Enrollment Periods Factsheet
An updated version of the Special Enrollment Periods (SEP) Fact Sheet was published in FebruaryNews Article updated on 03/15/2024